U.S. Metals and Mining Stock News

Ciena (CIEN) opened fiscal Q1 2026 with revenue of US$1.4b and basic EPS of US$1.06, putting a clear focus on how its income statement is scaling alongside earnings. The company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.4b in Q1 2026, while basic EPS shifted from US$0.31 to US$1.06 over the same period, set against trailing 12 month EPS of US$1.61. With net income and margins now playing a larger role in the story, this set of results points investors to profitability...

Recently, BioNTech highlighted its evolution from a COVID-19 vaccine leader into a broader biotech group focused on oncology, underscored by its acquisition of Chinese startup Biotheseus and a follow-on collaboration with Bristol Myers around antibody candidate BNT327 that includes upfront payments and future royalty sharing. An interesting implication is that BioNTech is now using targeted acquisitions as a platform to secure large-pharma partnerships, aiming to convert its oncology...

BGC Group (BGC) has been drawing attention after a recent move in its share price, with short term returns contrasting against its longer performance. This has prompted investors to reassess the brokerage and financial technology firm’s profile. See our latest analysis for BGC Group. At a latest share price of US$9.34, BGC Group’s recent 1 day and 7 day share price declines sit alongside a 30 day share price return of 3.9%, with multi year total shareholder returns above 90% indicating...

In early March 2026, Tango Therapeutics announced a clinical trial collaboration and supply agreement with Erasca to test Erasca’s pan-RAS molecular glue ERAS-0015 alongside Tango’s PRMT5 inhibitor vopimetostat in a Phase 1/2 study for MTAP-deleted pancreatic and RAS-mutant non-small cell lung cancers. This pairing targets a specific genetic vulnerability, MTAP deletion with co-occurring RAS mutations, offering a dual-mechanism approach that could help address resistance in these...

SS&C Technologies Holdings (SSNC) is back in focus after reporting an 8.1% year-on-year revenue increase, beating expectations and lifting full-year revenue and EPS guidance compared with earlier forecasts. See our latest analysis for SS&C Technologies Holdings. The latest results come after a mixed period for the stock, with a 2.84% 1 month share price return but a 14.19% 3 month share price decline and a 10.58% 1 year total shareholder return decline. However, the 3 year total shareholder...

Recent analyst commentary around Insmed (INSM) has centered on updated Brinsupri guidance for fiscal 2026 of at least US$1b in sales, along with expectations for a larger U.S. addressable market. See our latest analysis for Insmed. Despite the recent Brinsupri headlines, Insmed’s share price has softened in the near term, with a 30-day share price return of 8.08% and a 90-day return of 31.31%. At the same time, the 1-year total shareholder return of 87.11% and the very large 3-year total...

Super Group (SGHC) announced an increase to its annual dividend program. The company declared its first higher quarterly dividend under the new policy. The move signals a shift in how NYSE:SGHC is approaching shareholder returns. For investors watching NYSE:SGHC, this updated dividend approach comes after a period of mixed share performance. The stock is trading at $10.64, with a 30 day return of 18.4% and a 1 year return of 58.7%, while year to date performance shows an 8.6% decline. Over...

What Brighthouse Financial’s Recent Returns Mean For Investors Without a single headline event driving attention, Brighthouse Financial (BHF) has still caught investors’ eyes after a recent period of mixed share performance and solid reported revenue and net income figures. See our latest analysis for Brighthouse Financial. The recent 1 month share price return of 7.3% decline and 90 day share price return of 9.4% decline contrast with a 1 year total shareholder return of 9.2%. This suggests...

Tyson Foods and the University of Arkansas have agreed to a new jersey patch sponsorship for Razorback athletics, one of the early deals of its kind in college sports. The expanded partnership increases Tyson’s visibility across the university’s athletic programs and facilities. At the same time, U.S. lawmakers are renewing scrutiny of meat industry concentration, with Tyson Foods cited in discussions tied to elevated beef prices. Proposed legislation targets consolidation across the sector,...

Why Lear Stock Is Back On Investors’ Radar Lear (LEA) has drawn fresh attention after recent trading left the shares with mixed short term performance but a stronger past year, prompting investors to reassess how the auto supplier’s fundamentals line up with current pricing. See our latest analysis for Lear. After a softer patch that includes a 1 day share price return of 1.47% and a 7 day share price return of 8.43%, Lear still sits at US$120.18, with a 1 year total shareholder return of...

FIGS (NYSE:FIGS) recently highlighted accelerated international growth across key markets. The company reported strong operational performance alongside new consumer campaigns, including a program honoring women in healthcare. FIGS expanded its retail footprint with additional physical stores and pushed further into non scrub product lines. FIGS, known for its premium medical apparel, sits at the intersection of healthcare, retail, and lifestyle branding. As more healthcare professionals...

Guidewire Software Q2 2026 Earnings Snapshot Guidewire Software (GWRE) has put up another solid print for Q2 2026, with revenue at US$359.1 million and basic EPS of US$0.71, setting the tone for a cleaner run of profitability. The company has seen revenue move from US$289.5 million and basic EPS of US$0.45 loss in Q2 2025 to US$359.1 million and US$0.71 EPS in Q2 2026, while trailing 12 month EPS sits at US$2.24 on revenue of about US$1.3 billion, giving investors more visibility on earnings...

If you are wondering whether National Energy Services Reunited is still attractively priced after its recent run, you are not alone. This article is here to unpack the valuation story in a clear, practical way. The share price last closed at US$20.86, with a 1 year return of 163.4%, a 3 year return of 254.2%, and a year to date return of 32.1%. The stock has seen a 16.7% decline over the past 7 days and a 2.0% return over the past 30 days. Recent news flow around National Energy Services...

Illumina stock after recent performance Illumina (ILMN) has drawn fresh attention after a period where the share price has declined about 7% over the past month and roughly 3% over the past 3 months, despite a positive 1 year total return. See our latest analysis for Illumina. Short term momentum has faded for Illumina, with a 1 day share price decline of 2.82% and softer recent returns, even though the 1 year total shareholder return sits at 43.87%. If Illumina’s recent swings have you...

The FDA’s decision to lift the clinical hold on Intellia Therapeutics (NTLA) MAGNITUDE Phase 3 trial and the new hereditary angioedema data for lonvoguran ziclumeran have refocused attention on the company’s gene editing pipeline. See our latest analysis for Intellia Therapeutics. At a share price of $13.44, Intellia has seen a 39.85% 90 day share price return and a 45.93% year to date share price return. The 5 year total shareholder return of 79.49% and 3 year total shareholder return of...

BD (NYSE:BDX) received FDA 510(k) clearance for its Surgiphor 1000mL antimicrobial irrigation system designed for powered lavage, expanding its surgical solutions portfolio. The company also launched the BD Vacutainer Urine Complete Cup Kit, a three tube urine collection system intended to support more consistent sample quality and workflow efficiency. These back to back product milestones highlight ongoing activity in BD's medical and diagnostics franchises that could influence how...

In March 2026, Autohome Inc. reported past fourth-quarter and full-year 2025 results showing lower revenue and net income year-on-year, while also disclosing that it had repurchased 7,116,939 shares for US$184.50 million under its prior buyback plan. On the same day, the Board authorized a new US$200 million share repurchase program funded from existing cash, underlining management’s commitment to shareholder returns as Autohome advances its AI-driven, online-to-offline automotive service...

AGCO stock: recent move puts valuation in focus AGCO (AGCO) shares have been under pressure in the past week, with a 9.2% decline following a 2.9% drop in the latest session. This has put fresh attention on the agricultural equipment maker's current valuation and fundamentals. See our latest analysis for AGCO. That sharp 7 day share price return of negative 9.25% comes after a solid 90 day share price return of 17.69% and a 1 year total shareholder return of 21.86%. Recent momentum therefore...

Rigel Pharmaceuticals (RIGL) is back in focus after reporting fourth quarter and full year 2025 results, with revenue of US$69.8 million for the quarter and net income of US$268.07 million. See our latest analysis for Rigel Pharmaceuticals. Despite the strong Q4 and full year 2025 earnings, Rigel Pharmaceuticals' recent share price performance has been weak, with a 90 day share price return of 40.99% and a year to date share price return of 30.98%, while the 1 year total shareholder return of...

Jazz Pharmaceuticals reported record revenues for 2025 and highlighted strong Q4 results. The company completed regulatory filing for zanidatamab in gastroesophageal adenocarcinoma, positioning the therapy for potential approval and launch. Management emphasized ongoing expansion of its rare disease portfolio and upcoming clinical trial readouts. Shares of Jazz Pharmaceuticals (NasdaqGS:JAZZ) recently closed at $182.01, with the stock up 31.1% over the past year and 35.8% over three years...

If you are trying to figure out whether Tsakos Energy Navigation is attractively priced or not, this article will walk through what the current share price might be implying about the business. The stock most recently closed at US$34.75, with returns of 32.0% over 30 days, 58.7% year to date and 124.7% over the past year, alongside a 1.6% decline over the last week. Recent coverage around Tsakos Energy Navigation has focused on its role in the energy shipping sector and how investors are...

Recent share performance sets the stage Customers Bancorp (CUBI) has drawn fresh attention after a recent share pullback, with the stock down about 14% over the past month and roughly 5% over the past 3 months. See our latest analysis for Customers Bancorp. While the recent 14% one month share price pullback and 9.5% year to date share price decline may hint at fading short term momentum, the 34.3% one year total shareholder return and very large 195% three year total shareholder return show...

CoreWeave (NasdaqGS:CRWV) has been hit with a securities class action lawsuit alleging it overstated its ability to scale and downplayed delays tied to a single data center supplier. At the same time, the company is pursuing debt funded expansion, reporting soft near term revenue guidance, and ramping up large capital expenditures. At a share price of $72.99, CoreWeave is contending with a 7 day return of an 8.3% decline, a 30 day return of an 11.5% decline, and an 8.0% decline year to...

If you are wondering whether Marriott Vacations Worldwide is priced attractively right now, this article walks through what the current share price might be implying about its value. The stock closed at US$70.50 recently, with returns of 8.4% over the past week, 26.5% over the past month, 19.8% year to date, and 1.4% over the past year, alongside much weaker 3 and 5 year returns of 44.6% and 56.6% declines. These mixed returns mean some investors may see recent strength as a rebound, while...